ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

New Blood Thinner ‘Antidote’ to Help Doctors Move Past Warfarin

Bill Berkrot  |  December 28, 2015

NEW YORK (Reuters)—A new class of blood thinners that competes with widely used warfarin should get a boost next year when an “antidote” that can reverse the medications’ effects in an emergency is expected to enter the market, according to top U.S. heart doctors and investors. Xarelto, from Bayer AG and Johnson & Johnson, and…

Filed under:Drug Updates Tagged with:anticoagulantblood clotwarfarin

A Healthy Skepticism: Researchers Evaluate CNS Manifestations of Rheumatic Disease

Thomas R. Collins  |  December 22, 2015

SAN FRANCISCO—Let’s say your radiologist comes to you and says that an angiogram gives a diagnosis of CNS vasculitis on four patients, all with acute onset of headache and stroke: One is a 25-year-old woman who is three months pregnant. Another is a 50-year-old man using excessive doses of nasal decongestants. Another is a 40-year-old…

Filed under:ConditionsSjögren’s DiseaseVasculitis Tagged with:2015 ACR/ARHP Annual Meetingcentral nervous system vasculitisSjogren'ssystemic lupus erythematosus (SLE)

NIH-Funded Trials Dip While Industry Trials Are on the Rise

Kathryn Doyle  |  December 17, 2015

(Reuters Health)—Every year since 2006 in the U.S., the number of clinical trials funded by the National Institutes of Health (NIH) has gone down, while the number of industry-funded trials has gone up, a new study shows. Analyzing the ClinicalTrials.gov database, researchers found that after trial registration became a requirement for publication in major scientific…

Filed under:Drug Updates Tagged with:clinical trialsDrugsNational Institutes of Health (NIH)pharmaceutical companyPharmaceutical Research

Rheumatologist Rudy Molina, MD, Pursues Passion for Paleontology

Carol Patton  |  December 17, 2015

When Rodolfo “Rudy” Molina, MD, was 8 years old, a college recruiter visited his home. Unbeknownst to his parents, their son, now a rheumatologist at Arthritis Associates in San Antonio, Texas, had entered several of his drawings in a competition intended for high school students. The recruiter, unaware of the young artist’s age, was definitely…

Filed under:Professional TopicsProfiles Tagged with:CareerpaleontologyProfilerhuematologist

New President Dr. Von Feldt Looks at Where ACR Is Headed in 2016

Joan M. Von Feldt, MD, MSEd, FACR, FACP  |  December 17, 2015

I am honored, humbled and excited to serve as your ACR president. I’d like to share the following background information to illustrate the diverse set of life experiences I draw from to represent the ACR membership effectively. Personal Background Thanks to my mom, who was born and raised in Guatemala, I am bilingual in Spanish…

Filed under:President's Perspective Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Practice Managementprogressrheumatologytransformation

Air Pollution: Is There an Association with Rheumatic Disease?

Gavin R. Sun, MD, Sasha Bernatsky, MD, Gilaad G. Kaplan, MD, & Cheryl Barnabe, MD  |  December 17, 2015

Interactions between an individual’s genetic background and their exposure to environmental factors are thought to result in a cascade of immune reactions, ultimately leading to the development of autoimmune diseases such as rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), systemic lupus erythematosus (SLE) and juvenile dermatomyositis.1,2 For example, an environmental factor that conclusively affects susceptibility…

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:air pollutionenvironmentLupusRheumatic DiseaseRheumatoid arthritis

Rheumatology Coding Corner Question: Coding for Acute Flare of Idiopathic Gout

From the College  |  December 16, 2015

It has been two months since the implementation of ICD-10, so everyone has gotten a feel for the new code set. Let’s see how well you are doing in your diagnosis coding for rheumatology-specific conditions. A 55-year-old female patient presents for a follow-up visit of idiopathic chronic gout of multiple joints without tophi. She complains…

Filed under:Billing/CodingConditionsFrom the CollegeGout and Crystalline ArthritisPractice Support Tagged with:CodingCoding CornerDiagnosisGoutpatient carePractice ManagementrheumatologistTreatment

Best Practices for Treating Non-Specific Low Back Pain

Emma W. White, PT, DPT, OCS, & Andy Bonin, MD  |  December 16, 2015

Low back pain (LBP) is one of the most common reasons for physician appointments. However, treatment results remain suboptimal, resulting in high rates of chronic pain, narcotic usage, surgery, depression and disability—all at great cost to individuals and the nation. One reason for this is the current practice of grouping all low back pain patients…

Filed under:Clinical Criteria/GuidelinesConditions Tagged with:Clinical GuidelinesLBPlow back painpatient careTreatment

Rheumatologists Remember Dr. Engleman, Pioneer, Leader, ‘Full Human Being’

Gretchen Henkel  |  December 16, 2015

Two years ago, at the age of 102, rheumatologist Ephraim P. Engleman, MD, FACR, FACP, published a memoir, My Century, in which he detailed his personal and professional accomplishments, as well as his secrets to longevity. With his characteristic sense of humor, Dr. Engleman noted that the first secret to a long life is to…

Filed under:Professional TopicsProfiles Tagged with:CareerEphraim P. EnglemanProfilerhuematologist

A Brief History of American Rheumatology

Maria J. Antonelli, MD, Cassandra M. Calabrese, DO, Leonard H. Calabrese, DO, & Irving Kushner, MD  |  December 16, 2015

In medicine, as in all other areas of human endeavor, we cannot really understand where we are if we don’t understand how we arrived here. American rheumatology traces its origins nine decades back to Europe, when the International Committee on Rheumatism was founded by Jan van Breeman in 1925 at a European meeting of medical…

Filed under:Professional Topics Tagged with:Historyrheumatology

  • « Previous Page
  • 1
  • …
  • 235
  • 236
  • 237
  • 238
  • 239
  • …
  • 337
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences